# NextCure, Inc.: Form 8-K, filed Mar 21, 2024

- Company: [NextCure, Inc.](/companies/nxtc.md) (CIK 1661059)
- Form: 8-K
- Filed: 2024-03-21
- Accepted by EDGAR: Mar 21, 2024, 09:00 ET
- Period: 2024-03-21
- Accession: 0001558370-24-003671
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1661059/000155837024003671/nxtc-20240321x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1661059/000155837024003671/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1661059/000155837024003671/nxtc-20240321x8k.htm

Filed Mar 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-003671. Last ingested by Listed: Nov 2, 2026, 06:06 ET. No prices; not investment advice.